DENVER, Dec. 05, 2016 -- Air Methods Corporation (Nasdaq:AIRM), the global leader in air medical transportation, today reported preliminary patient transport and tourism passenger data for the month of November 2016.
| Air Medical | Nov-16 | Nov-15 | YOY Change (%) | QTD 4Q16 | QTD 4Q15 | YOY Change (%) | ||||
| Transports | 5,933 | 5,240 | 13.2 | % | 12,431 | 11,082 | 12.2 | % | ||
| Transports + Weather Cancellations | 7,629 | 7,566 | 0.8 | % | 15,641 | 15,093 | 3.6 | % | ||
| Same-Base Transports (SBTs) | 5,257 | 5,015 | 4.8 | % | 10,663 | 10,357 | 3.0 | % | ||
| SBT + Weather Cancellations | 6,791 | 7,247 | -6.3 | % | 13,530 | 14,166 | -4.5 | % | ||
| Tourism | Nov-16 | Nov-15 | YOY Change (%) | QTD 4Q16 | QTD 4Q15 | YOY Change (%) | ||||
| Passengers | 30,890 | 30,410 | 1.6 | % | 72,106 | 71,242 | 1.2 | % | ||
About Air Methods Corporation
Air Methods Corporation (www.airmethods.com) is the global leader in air medical transportation. The Air Medical Services Division is the largest provider of air medical transport services in the United States. The United Rotorcraft Division specializes in the design and manufacture of aeromedical and aerospace technology. The Tourism Division is comprised of Sundance Helicopters, Inc. and Blue Hawaiian Helicopters, which provide helicopter tours and charter flights in the Las Vegas/Grand Canyon region and Hawaii, respectively. Air Methods’ fleet of owned, leased or maintained aircraft features approximately 500 helicopters and fixed wing aircraft.
Forward Looking Statements: Forward-looking statements in this news release are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Statements in this press release that are “forward-looking statements”, including statements we make with regard to preliminary results of (i) total transports, (ii) same-base transports, (iii) weather cancellations, (iv) weather cancellations as a percent of requests, and (v) tourism passengers for November 2016 are based on current expectations and assumptions that are subject to risks and uncertainties. Actual results could differ materially from those currently anticipated due to a number of factors, including but not limited to the Company’s completion of its third quarter closing and review procedures and other matters set forth in the Company's filings with the SEC. The Company is under no obligation (and expressly disclaims any obligation) to update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
CONTACTS: Peter P. Csapo, Chief Financial Officer, ([email protected]). Please contact Christina Brodsly Ward at ([email protected]) to be included on the Company’s e-mail distribution list.


Boeing Seeks FAA Emissions Waiver to Continue 777F Freighter Sales Amid Strong Cargo Demand
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays
U.S. Lawmakers Urge Pentagon to Blacklist More Chinese Tech Firms Over Military Ties
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement
Seatrium Reaches $475 Million Settlement With Maersk Over Offshore Wind Vessel Project
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Dina Powell McCormick Resigns From Meta Board After Eight Months, May Take Advisory Role
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage
Elon Musk Wins Reinstatement of Historic Tesla Pay Package After Delaware Supreme Court Ruling
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 



